JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,823,593 | -16.8% | 2,067,468 | -2.0% | 0.01% | -12.5% |
| Q2 2023 | $25,031,210 | +10.7% | 2,109,338 | +12.9% | 0.02% | +6.7% |
| Q1 2023 | $22,611,527 | -6.5% | 1,869,076 | +1.7% | 0.02% | -11.8% |
| Q4 2022 | $24,173,460 | -9.0% | 1,837,791 | -53.1% | 0.02% | -15.0% |
| Q3 2022 | $26,572,546 | +2.3% | 3,920,088 | +84.2% | 0.02% | +11.1% |
| Q2 2022 | $25,966,000 | -22.6% | 2,127,797 | -9.0% | 0.02% | +12.5% |
| Q1 2022 | $33,542,000 | -28.0% | 2,339,146 | -2.6% | 0.02% | -15.8% |
| Q4 2021 | $46,558,000 | -9.4% | 2,400,893 | -0.6% | 0.02% | -13.6% |
| Q3 2021 | $51,375,000 | -20.4% | 2,416,404 | -9.4% | 0.02% | -21.4% |
| Q2 2021 | $64,522,000 | – | 2,668,207 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |